MRK Insider Trading

Insider Ownership Percentage: 0.09%
Insider Buying (Last 12 Months): $250,012.25
Insider Selling (Last 12 Months): $209,562.36

Merck & Co., Inc. Insider Trading History Chart

This chart shows the insider buying and selling history at Merck & Co., Inc. by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$100M-$50M$0$50M$100MTotal Insider BuyingTotal Insider Selling

Merck & Co., Inc. Share Price & Price History

Current Price: $83.20
Price Change: Price Increase of +0.46 (0.56%)
As of 04/28/2025 04:59 PM ET

This chart shows the closing price history over time for MRK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$83.20Closing price on 04/28/25:

SEC Filings (Institutional Ownership Changes) for Merck & Co., Inc. (NYSE:MRK)

76.07% of Merck & Co., Inc. stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MRK by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$798Mbought$790MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$100B$0$100BTotal InflowsTotal Outflows
Merck & Co., Inc. logo
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Read More on Merck & Co., Inc.

Today's Range

Now: $83.20
Low: $82.40
High: $83.68

50 Day Range

MA: $87.00
Low: $76.42
High: $95.13

52 Week Range

Now: $83.20
Low: $75.93
High: $134.63

Volume

14,235,803 shs

Average Volume

11,870,150 shs

Market Capitalization

$209.81 billion

P/E Ratio

12.36

Dividend Yield

3.92%

Beta

0.4

Who are the company insiders with the largest holdings of Merck & Co., Inc.?

Merck & Co., Inc.'s top insider shareholders include:
  1. Richard R Deluca (EVP)
  2. Rita A Karachun (VP)
  3. Steven Mizell (EVP)
  4. Joseph Romanelli (Insider)
  5. Johannes Jacobus Oosthuizen (Insider)
  6. Cristal N Downing (Insider)
  7. Inge G Thulin (Director)
Learn More about top insider investors at Merck & Co., Inc..

Who are the major institutional investors of Merck & Co., Inc.?

Merck & Co., Inc.'s top institutional shareholders include:
  1. Sumitomo Mitsui Trust Group Inc. — 0.29%
  2. Principal Financial Group Inc. — 0.22%
  3. Rhumbline Advisers — 0.18%
  4. GAMMA Investing LLC — 0.17%
  5. Robeco Institutional Asset Management B.V. — 0.10%
  6. KBC Group NV — 0.09%
Learn More about top institutional investors of Merck & Co., Inc. stock.

Which institutional investors are selling Merck & Co., Inc. stock?

During the previous quarter, MRK stock was sold by these institutional investors:
  1. Handelsbanken Fonder AB
  2. Principal Financial Group Inc.
  3. Retirement Systems of Alabama
  4. Compagnie Lombard Odier SCmA
  5. IMC Chicago LLC
  6. Allspring Global Investments Holdings LLC
  7. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH
  8. KBC Group NV

Which institutional investors are buying Merck & Co., Inc. stock?

During the last quarter, MRK stock was acquired by institutional investors including:
  1. GAMMA Investing LLC
  2. Sarasin & Partners LLP
  3. Mirae Asset Global Investments Co. Ltd.
  4. AEGON ASSET MANAGEMENT UK Plc
  5. Compass Capital Management Inc.
  6. CX Institutional
  7. Foster Victor Wealth Advisors LLC
  8. Wealth Enhancement Advisory Services LLC